Gore Peripheral Vision - Vol 001 - February 2009


	goremedical.com \| gore.com \| all products \| careers


	NEWS Gore Launches Third Generation GORE VIABAHN® Endoprosthesis in Europe Gore Receives CE Mark for GORE VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface Reimbursement Update CASE STUDY Case Study: GORE PROPATEN® Vascular Graft and Heparin Induced Thrombocytopenia			PRODUCT UPDATES New Line Extensions for GORE PROPATEN® Vascular Grafts CLINICAL STUDY UPDATES Gore Makes Headway with Current Clinical Studies EVENTS 2009 Events CLINICAL LITERATURE Literature Recommendations
	Printable PDF Version \| Download Adobe Reader


	Gore Launches Third Generation GORE VIABAHN^® Endoprosthesis in Europe
	W. L. Gore & Associates (Gore) formally launched their third generation GORE VIABAHN^® Endoprosthesis at the recent CIRSE meeting in Copenhagen, Denmark. The launch was accompanied by talks from Eric Verhoeven, MD, University Medical Center, Groningen, Paramjit "Romi" Chopra, MD Rush University, Chicago, and Professor Johannes Lammer Medizinische Universitat, Wien. Dr. Verhoeven of University Medical Center, Groningen, presented improved patency rates in... More


	Gore Receives CE Mark for GORE VIABAHN^® Endoprosthesis with PROPATEN Bioactive Surface
	Gore received approval to apply the CE Mark and commence commercial distribution of its GORE VIABAHN^® Endoprosthesis with PROPATEN Bioactive Surface in the European Union. Additionally, Gore recently received approval by the Therapeutic Goods Administration to commence commercial distribution in Australia. The GORE VIABAHN^® Endoprosthesis with PROPATEN Bioactive... More


	Reimbursement Update
	PHYSICIAN NEWS The CMS issued a correction to the Transitional PE Non-Facility RVU for two CPT^® Codes, 37205 Transcatheter placement of an intravascular stent(s) (except coronary, carotid, and vertebral vessel), percutaneous; initial vessel and 37206 Transcatheter placement of an intravascular stent(s) (except coronary, carotid, and vertebral vessel), percutaneous; additional vessel. Initially the Transitional PE Non-Facility RVU for CPT^® Code 37205 was published as 65.13 and corrected to 108.66, for CPT^® Code 37206 was published as 38.41 and corrected to 66.45. These corrections were published in the CMS Transmittal 1528 dated May 30, 2008 and effective retroactive to January 1, 2008. PHYSICIAN AND HOSPITAL OUTPATIENT NEWS The NCCI Edit Manual published by CMS, provides additional CPT^® Coding guidance for physicians and hospital outpatient providers. A revised NCCI Edit in Chapter 6, Section D, Paragraph 16, was issued by the CMS effective January 1, 2008 for coding atherectomy, angioplasty and stent placement procedures in the same vessel. There were requests from Medical Societies and other stakeholders to rescind this Edit as it did not conform with CPT^® Coding Guidelines developed by the American Medical Association (AMA). In July 2008, the CMS rescinded this NCCI Edit and reverted to the original guidance. The NCCI Edit Manual is published on the CMS website. A detail article describing this issue has been published in the October 2008 Issue of Endovascular Today. HOSPITAL INPATIENT NEWS The Medicare Inpatient Prospective Payment System (IPPS) payment rates and rules were published for the FFY 2009 annual update effective October 1, 2008. Coding Brochures for these FFY 2009 Medicare National Hospital Inpatient payment rates may be found on the Gore website, wwww.goremedical.com/ reimbursement/. Also posted on the website are the Medicare IPPS Table 6I - MCCs list and Table 6J - CCs list which are utilized in the Medicare Severity Diagnosis Related Groups (MS-DRG) methodology.


	Case Study: GORE PROPATEN^® Vascular Graft and Heparin Induced Thrombocytopenia
	Karthikeshwar Kasirajan, MD Division of Vascular Surgery Emory University School of Medicine, Atlanta, GA. CLINICAL CHALLENGE The patient was a 41-year-old female with gangrene of the first and fifth toes of the right foot for six months. The patient had a history of heavy smoking (> 20 cigarettes / day) without any other significant risk factors. Angiography of the right lower extremity revealed total Superficial Femoral Artery... More


	New Line Extensions for GORE PROPATEN^® Vascular Grafts
	The GORE PROPATEN^® Vascular Graft was commercialized in the US in December 2006. Since its introduction, the GORE PROPATEN^® Vascular Graft has become the standard-of-care vascular graft in several prestigious institutions around the world. In order to meet physician and patient needs, we have been actively working to release new line extensions and anticipate having a full portfolio.... More


	Gore Makes Headway with Current Clinical Studies
	The Gore VIPER Patient Registry is a prospective, single-arm, multi-center evaluation of the GORE VIABAHN^® Endoprosthesis with Heparin Bioactive Surface in the treatment of superficial femoral artery obstructive disease that will collect important performance data of the device. Forty subjects have been enrolled at six centers in the US. Subjects will be followed for one year. More

2009 Events

Date			Name		Location		Website
Feb 19 - 21	2009		Sanctuary of Endovascular Therapy (SET)		Kiawah Island, South Carolina		www.setmeeting.org
Feb 26 - 28	2009		European Vascular Course (EVC)		Maastricht, The Netherlands		www.evc-meeting.org
Mar 7 - 12	2009		Society of Interventional Radiology (SIR)		San Diego, California		www.sirmeeting.org
Mar 16 - 19	2009		The Society for Cardiovascular Angiography and Interventions Cabo Interventional Summit		Cabo San Lucas, Mexico		www.scai.org
Mar 18 - 20	2009		Endovascular Therapy International (ETI)		Genova, Italy		www.eti-endovascular.org
Mar 18 - 21	2009		Society for Clinical Vascular Surgery (SCVS)		Fort Lauderdale, Florida		www.scvs.vascularweb.org
Mar 22 - 23	2009		6th International Workshop on Interventional Pediatric Cardiology		MIlano, Italy		www.workshopipc.com
Apr 4 - 7	2009		Charing Cross 29th International Symposium		London, England		www.cxsymposium.com
Apr 22 - 24	2009		6th Vienna Interdisciplinary Symposium on Aortic Repair (VISAR)		Vienna, Austria		www.visar.at
May 19 - 22	2009		European Association of Percutaneous Cardiovascular Interventions (PCR)		Barcelona, Spain		www.europcr.com
May 29	2009		Masterclass		London, England
May 31 - Jun 2	2009		European Sociaty of Thoracic Surgeons (ESTS)		Krakow, Poland		www.ests.org


	Literature Recommendations
		DIALYSIS Morsy MA, Khan A, Chemla ES. Prosthetic axillary-axillary arteriovenous straight access (necklace graft) for difficult hemodialysis patients: a prospective singlecenter experience. Journal of Vascular Surgery ; in press.
		PERIPHERAL VASCULAR TREATMENT Banerjee S, Brilakis ES, Das TS. Covered stents for the treatment of SFA occlusive disease. Endovascular Today 2008;7(10):41-46. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. Journal of Vascular Surgery 2008;48(3):619-625. Dorigo W, Di Carlo F, Troisi N, et al. Lower limb revascularization with a new bioactive prosthetic graft: early and late results. Annals of Vascular Surgery 2008;22(1):79-87. Heyligers JMM, Lisman T, Verhagen HJM, Weeterings C, de Groot PG, Moll FL. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans. Journal of Vascular Surgery 2008;47(2): 324-329. Hoeks SE, Smolderen KG, Scholte op Reimer WJM, Verhagen HJM, Spertus JA, Poldermans D. Clinical validity of a disease-specific health status questionnaire: The Peripheral Artery Questionnaire. Journal of Vascular Surgery; in press. Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL Sr. Goshima KR, Echeverri JA, Arslan B. Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score. Journal of Vascular Surgery 2008;47(5):967-974. Peeters P, Verbist J, Deloose K, Bosiers M. Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass? Italian Journal of Vascular & Endovascular Surgery 2008;15(3):143-148. Powell RJ. Endovascular Treatment in the Superficial Femoral Artery: Which Devices, Where? Seminars in Vascular Surgery 2008;21(4):180-185. Schmieder GC, Panneton JM. Endovascular Superficial Femoral Artery Treatment: Can it Be as Good as Bypass? Seminars in Vascular Surgery 2008;21(4):186-194.
		TIPS Pan JJ , Chen C, Geller B, et al. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents. Clinical Radiology 2008;63(10):1142-1148.


	Have a story idea or case study to share? Send your suggestions to peripheralvision@wlgore.com To subscribe to Gore Peripheral Vision, click here or contact your local Gore Sales Associate.